Amphastar Pharmaceuticals
AMPH
AMPH
213 hedge funds and large institutions have $764M invested in Amphastar Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 71 increasing their positions, 83 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
9% less capital invested
Capital invested by funds: $839M → $764M (-$74.8M)
14% less repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 83
Holders
213
Holding in Top 10
1
Calls
$1.34M
Puts
$316K
Top Buyers
| 1 | +$6.47M | |
| 2 | +$2.6M | |
| 3 | +$2.34M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$1.82M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$1.63M |
Top Sellers
| 1 | -$6.03M | |
| 2 | -$4.91M | |
| 3 | -$3.72M | |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$3.25M |
| 5 |
BlackRock
New York
|
-$3.06M |